Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 3:44 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1993–2016 of 18,269 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Controlled Group Clear all

Conditions: Thrombocytopenia Associated With Liver Disease
Interventions: avatrombopag (lower baseline platelet count), placebo (lower baseline platelet count), avatrombopag (higher baseline platelet count), placebo (higher baseline platelet count); Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 231 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 21
States / cities: Lancaster, California • Long Beach, California • Los Angeles, California + 18 more

Conditions: Premature Ejaculation
Interventions: GSK557296, placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 6
States / cities: San Diego, California • San Jose, California • Fort Wayne, Indiana + 3 more

Conditions: Knee Osteoarthritis
Interventions: Model, Knee Anatomy Video, Verbal; Behavioral
Lead sponsor: University of Missouri, Kansas City; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2016
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Arthritis, Psoriatic
Interventions: Sonelokimab, Placebo, Adalimumab; Drug
Lead sponsor: MoonLake Immunotherapeutics AG; Industry
Eligibility: 18 Years and older
Enrollment: 207 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Rancho Mirage, California • Duncansville, Pennsylvania

Conditions: Threat Sensitivity
Interventions: Stress and Mindfulness Intervention; Behavioral
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Malignant Solid Neoplasm
Interventions: Best Practice, Educational Intervention, Electronic Health Record Review, Interview, Questionnaire Administration, Telephone-Based Intervention; Other · Behavioral
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years and older
Enrollment: 1,020 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2032
U.S. locations: 7
States / cities: Little Rock, Arkansas • Honolulu, Hawaii • Danville, Illinois + 4 more

Conditions: Venous Thromboembolism
Interventions: dabigatran etexilate, standard of care; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: Up to 17 Years
Enrollment: 267 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 9
States / cities: Sacramento, California • Miami, Florida • Tampa, Florida + 6 more

Conditions: Pregnancy, Cesarean Section, Prescriptions, Analgesics, Opioid
Interventions: Prescribed opioids; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cardiovascular Diseases, Hypertension
Interventions: Williams LifeSkills Stress and Anger Management Workshop, High school classes; Behavioral
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 14 Years to 18 Years
Enrollment: 259 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 3
States / cities: Augusta, Georgia • Durham, North Carolina

Conditions: Colorectal Surgery, Ileus
Interventions: Alvimopan, Control Group; Drug · Other
Lead sponsor: Sharon Stein; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cardiovascular Diseases, Diabetes Mellitus, Hypertension, Dyslipidemias, Overweight and Obesity
Interventions: Lifestyle Modification; Behavioral
Lead sponsor: Ohio University; Other
Eligibility: 12 Years and older
Enrollment: 861 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Athens, Ohio

Conditions: Scar Tissue, Hypertrophic Scar, Hypertrophic Scar of Upper Arm (Disorder), Hypertrophic Surgical Scar, Dry Needling
Interventions: True dry needling, Sham dry needling; Other
Lead sponsor: Iran University of Medical Sciences; Other
Eligibility: 20 Years to 60 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Patellofemoral Pain Syndrome, Anterior Knee Pain Syndrome
Interventions: Psychologically Informed Education Video, Anatomy Education Video; Other
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 12 Years to 18 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Delirium, Confusion
Interventions: Confusion Assessment Method, Accelerometer, Commercially available camera, Internet Pod (iPod), Cortisol Swab; Behavioral · Device · Diagnostic Test
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis
Interventions: HealthPROMISE users, Control Group; Other
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Rotator Cuff Tears
Interventions: Clomiphene Citrate, Rotator Cuff Repair; Drug · Procedure
Lead sponsor: University of Utah; Other
Eligibility: 40 Years to 80 Years · Male only
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Major Depressive Disorder
Interventions: Repetitive Transcranial Magnetic Stimulation; Device
Lead sponsor: Neuronetics; Other
Eligibility: 18 Years to 70 Years
Enrollment: 286 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 13
States / cities: Poway, California • Stanford, California • Chicago, Illinois + 9 more

Conditions: Spine Fusion, Surgery, Pain, Postoperative
Interventions: 0.25% Marcaine at 2ml/hr and pain medications, Placement of OnQ Drug pump; Drug · Device
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Depression, Posttraumatic Stress Disorder, Pregnancy Related, Medication Adherence
Interventions: Brief CBT-Based Intervention, Enhanced Treatment as Usual; Behavioral · Other
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 15 Years and older · Female only
Enrollment: 118 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Tularaemia
Interventions: Placebo, Undiluted Francisella tularensis live attenuated vaccine; Other · Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 228 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 5
States / cities: Decatur, Georgia • Iowa City, Iowa • Baltimore, Maryland + 2 more

Conditions: Morbid Obesity, Bariatric Surgery Patient
Interventions: Not listed
Lead sponsor: Oregon Weight Loss Surgery, LLC; Other
Eligibility: 18 Years to 69 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2024
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Peri-implant Mucositis
Interventions: Simvastatin, Placebo; Drug · Other
Lead sponsor: Ahmed Mohamed Mahrous; Other
Eligibility: 18 Years to 80 Years
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Human Immunodeficiency Virus (HIV), Sexually Transmitted Disease (STD)
Interventions: STAND HIV Risk Reduction Intervention, Text Messaging Intervention; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 391 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Caregiver Burden
Interventions: Options Counselor Health Educator (OC-HE) Intervention; Behavioral
Lead sponsor: Sato Ashida; Other
Eligibility: 18 Years to 110 Years
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Iowa City, Iowa

Search by objective public record fields.

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation

The Age of OrthoInfo: A Randomized Controlled Trial Evaluating Patient Comprehension of Informed Consent in a Private Practice

Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis

Reactions to Distress (RED) In Louisville, KY Study

Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams

Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)

Shared Decision Making for Prescription Opioids After Cesarean Delivery

Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth

Alvimopan as Rescue in Post op Ileus

Peru Longitudinal Study

Effectiveness of Dry Needling in Linear Scar Tissue

The Effect of Psychologically Informed Education in Adolescents With Patellofemoral Pain

Intelligent Intensive Care Unit

Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of Life

Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial

Study of a Repetitive Transcranial Magnetic Stimulation (rTMS) Device for the Treatment of Major Depressive Disorder

Postoperative subQ Pain Control for Spinal Fusion Surgery

Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa

Phase II Tularemia Vaccine Comparison

Appetite Suppression / Hormone Study Control Group

Use of Topical Subgingival Application of Simvastatin Gel in the Treatment of Peri-Implant Mucositis

Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American Men

Building a Bridge (BAB) Between Clinical and Community Care